Deferred Income Tax Assets, Net of IDEXX LABORATORIES INC /DE from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
IDEXX LABORATORIES INC /DE quarterly Deferred Income Tax Assets, Net in USD history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • IDEXX LABORATORIES INC /DE Deferred Income Tax Assets, Net for the quarter ending 30 Sep 2025 was $31,497,000, a 77% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Deferred Income Tax Assets, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $31,497,000 -$103,180,000 -77% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $125,021,000 -$1,036,000 -0.82% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $123,081,000 +$16,564,000 +16% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $125,630,000 +$18,266,000 +17% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $134,677,000 +$65,708,000 +95% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $126,057,000 +$60,720,000 +93% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $106,517,000 +$49,381,000 +86% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $107,364,000 +$52,149,000 +94% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $68,969,000 +$17,034,000 +33% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $65,337,000 +$24,789,000 +61% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $57,136,000 +$34,045,000 +147% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $55,215,000 +$30,431,000 +123% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $51,935,000 +$27,074,000 +109% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $40,548,000 +$13,778,000 +51% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $23,091,000 -$5,249,000 -19% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $24,784,000 -$6,765,000 -21% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $24,861,000 +$16,663,000 +203% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $26,770,000 +$19,195,000 +253% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $28,340,000 +$21,168,000 +295% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $31,549,000 +$23,449,000 +289% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $8,198,000 -$201,000 -2.4% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $7,575,000 -$1,164,000 -13% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $7,172,000 -$1,196,000 -14% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $8,100,000 -$381,000 -4.5% 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 $8,399,000 -$37,000 -0.44% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $8,739,000 +$16,000 +0.18% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $8,368,000 -$1,455,000 -15% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $8,481,000 +$783,000 +10% 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 $8,436,000 +$522,000 +6.6% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 $8,723,000 +$2,022,000 +30% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 $9,823,000 +$3,956,000 +67% 31 Mar 2018 10-Q 04 May 2018 2018 Q1
Q4 2017 $7,698,000 +$1,991,000 +35% 31 Dec 2017 10-K 15 Feb 2019 2018 FY
Q3 2017 $7,914,000 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 $6,701,000 30 Jun 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 $5,867,000 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $5,707,000 31 Dec 2016 10-K 16 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.